Die hard

Are cancer stem cells the bruce willises of tumor biology?

Ákos Fábián, Márk Barok, G. Vereb, J. Szöllősi

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

In recent years, an exponentially growing number of studies have focused on identifying cancer stem cells (CSC) in human malignancies. The rare CSCs could be crucial in controlling and curing cancer: through asymmetric division CSCs supposedly drive tumor growth and evade therapy with the help of traits shared with normal stem cells such as quiescence, self-renewal ability, and multidrug resistance pump activity. Here, we give a brief overview of techniques used to confirm the stem cell-like behavior of putative CSCs and discuss markers and methods for identifying, isolating, and culturing them. We touch on the limitations of each marker and why the combined use of CSC markers, in vitro and in vivo assays may still fail to identify all relevant CSC populations. Finally, the various experimental findings supporting and contradicting the CSC hypothesis are summarized. The large number of tumor types thus far with a subpopulation of uniquely tumorigenic and therapy resistant cells suggests that despite the unanswered questions and inconsistencies, the CSC hypothesis has a legitimate role to play in tumor biology. At the same time, experimental evidence supporting the established alternative theory of clonal evolution can be found as well. Therefore, a model that describes cancer initiation and progression should combine elements of clonal evolution and CSC theory.

Original languageEnglish
Pages (from-to)67-74
Number of pages8
JournalCytometry Part A
Volume75
Issue number1
DOIs
Publication statusPublished - Jan 2009

Fingerprint

Neoplastic Stem Cells
Clonal Evolution
Neoplasms
Stem Cells
Aptitude
Multiple Drug Resistance
Cell- and Tissue-Based Therapy
Growth
Population

Keywords

  • Cancer stem cells
  • Clonal evolution
  • Progenitor cells
  • Stem cell markers
  • Therapy resistance

ASJC Scopus subject areas

  • Cell Biology
  • Histology
  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

Die hard : Are cancer stem cells the bruce willises of tumor biology? / Fábián, Ákos; Barok, Márk; Vereb, G.; Szöllősi, J.

In: Cytometry Part A, Vol. 75, No. 1, 01.2009, p. 67-74.

Research output: Contribution to journalArticle

@article{4183ff1f78fa4e7aa47abeee1d67a5a1,
title = "Die hard: Are cancer stem cells the bruce willises of tumor biology?",
abstract = "In recent years, an exponentially growing number of studies have focused on identifying cancer stem cells (CSC) in human malignancies. The rare CSCs could be crucial in controlling and curing cancer: through asymmetric division CSCs supposedly drive tumor growth and evade therapy with the help of traits shared with normal stem cells such as quiescence, self-renewal ability, and multidrug resistance pump activity. Here, we give a brief overview of techniques used to confirm the stem cell-like behavior of putative CSCs and discuss markers and methods for identifying, isolating, and culturing them. We touch on the limitations of each marker and why the combined use of CSC markers, in vitro and in vivo assays may still fail to identify all relevant CSC populations. Finally, the various experimental findings supporting and contradicting the CSC hypothesis are summarized. The large number of tumor types thus far with a subpopulation of uniquely tumorigenic and therapy resistant cells suggests that despite the unanswered questions and inconsistencies, the CSC hypothesis has a legitimate role to play in tumor biology. At the same time, experimental evidence supporting the established alternative theory of clonal evolution can be found as well. Therefore, a model that describes cancer initiation and progression should combine elements of clonal evolution and CSC theory.",
keywords = "Cancer stem cells, Clonal evolution, Progenitor cells, Stem cell markers, Therapy resistance",
author = "{\'A}kos F{\'a}bi{\'a}n and M{\'a}rk Barok and G. Vereb and J. Sz{\"o}llősi",
year = "2009",
month = "1",
doi = "10.1002/cyto.a.20690",
language = "English",
volume = "75",
pages = "67--74",
journal = "Cytometry. Part A : the journal of the International Society for Analytical Cytology",
issn = "1552-4922",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Die hard

T2 - Are cancer stem cells the bruce willises of tumor biology?

AU - Fábián, Ákos

AU - Barok, Márk

AU - Vereb, G.

AU - Szöllősi, J.

PY - 2009/1

Y1 - 2009/1

N2 - In recent years, an exponentially growing number of studies have focused on identifying cancer stem cells (CSC) in human malignancies. The rare CSCs could be crucial in controlling and curing cancer: through asymmetric division CSCs supposedly drive tumor growth and evade therapy with the help of traits shared with normal stem cells such as quiescence, self-renewal ability, and multidrug resistance pump activity. Here, we give a brief overview of techniques used to confirm the stem cell-like behavior of putative CSCs and discuss markers and methods for identifying, isolating, and culturing them. We touch on the limitations of each marker and why the combined use of CSC markers, in vitro and in vivo assays may still fail to identify all relevant CSC populations. Finally, the various experimental findings supporting and contradicting the CSC hypothesis are summarized. The large number of tumor types thus far with a subpopulation of uniquely tumorigenic and therapy resistant cells suggests that despite the unanswered questions and inconsistencies, the CSC hypothesis has a legitimate role to play in tumor biology. At the same time, experimental evidence supporting the established alternative theory of clonal evolution can be found as well. Therefore, a model that describes cancer initiation and progression should combine elements of clonal evolution and CSC theory.

AB - In recent years, an exponentially growing number of studies have focused on identifying cancer stem cells (CSC) in human malignancies. The rare CSCs could be crucial in controlling and curing cancer: through asymmetric division CSCs supposedly drive tumor growth and evade therapy with the help of traits shared with normal stem cells such as quiescence, self-renewal ability, and multidrug resistance pump activity. Here, we give a brief overview of techniques used to confirm the stem cell-like behavior of putative CSCs and discuss markers and methods for identifying, isolating, and culturing them. We touch on the limitations of each marker and why the combined use of CSC markers, in vitro and in vivo assays may still fail to identify all relevant CSC populations. Finally, the various experimental findings supporting and contradicting the CSC hypothesis are summarized. The large number of tumor types thus far with a subpopulation of uniquely tumorigenic and therapy resistant cells suggests that despite the unanswered questions and inconsistencies, the CSC hypothesis has a legitimate role to play in tumor biology. At the same time, experimental evidence supporting the established alternative theory of clonal evolution can be found as well. Therefore, a model that describes cancer initiation and progression should combine elements of clonal evolution and CSC theory.

KW - Cancer stem cells

KW - Clonal evolution

KW - Progenitor cells

KW - Stem cell markers

KW - Therapy resistance

UR - http://www.scopus.com/inward/record.url?scp=59049105873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59049105873&partnerID=8YFLogxK

U2 - 10.1002/cyto.a.20690

DO - 10.1002/cyto.a.20690

M3 - Article

VL - 75

SP - 67

EP - 74

JO - Cytometry. Part A : the journal of the International Society for Analytical Cytology

JF - Cytometry. Part A : the journal of the International Society for Analytical Cytology

SN - 1552-4922

IS - 1

ER -